These guidelines were updated in 2006/7 by a subgroup representing the majority of the same professional
organisations in the light of advances in diagnosis and management of thyroid cancer. They placed emphasis
on tailoring the aggressiveness of treatment and monitoring to the individual patient and the central role of the
multidisciplinary team meetings in making these decisions, based on risk assessment.